This approval makes Eli Lillys oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug available in pill form, after Wegovy, which gained approval in December 2025
Interested members complete an intake questionnaire, submit a body photo, verify their identity and connect with a licensed clinician, who determines whether a microdosed GLP-1 prescription is appropriate
Programs that sell peptides labeled research use only with no prescriber involved were excluded automatically that isnt telehealth, its an unregulated chemical supplier
10.1080/19490976.2015.1134082 Gut Microbes
(2024) reported that epileptic seizures can induce microglial activation and trigger a cascade involving the NOD-, LRR-and pyrin domain-containing protein 3 (NLRP3) inflammasome, leading to elevated pro-inflammatory cytokine levels, aggravated neuronal damage, and depression-like behaviors
Injecting in the same spot repeatedly causes lipohypertrophy